Surprising Highland Capital Management’s Q3
On 3 February 2016, James Dondero’s Highland Capital Management released it Q3 (third quarterly) financial report. Their overall hedge fund portfolio suffered a reduction to $3.42 billion from its previous quarter at $4.91billion. This simultaneously affected their allocations to various sectors that fall under the hedge fund portfolio. The reductions are as follows: Healthcare at 20%, Information technology and finance at 18% each, energy at 12% and lastly, consumer discretionary at 10%. These sectors have allocations, which are below the previous quarter.
However, it the company did not suffer losses only with their reduced portfolio. Between the Q2 and Q3, the company made purchases to several companies, therefore increasing their assets. These companies include Spdr S&P 500 (1.96%), Amazon Com Inc (0.68%), Eagle Pharmaceutical Inc (0.52%), Danaher Corp Del (0.5%) and Intra cellular Therapies Inc (0.46%).
James Dondero, commonly known as Jim, is the co-founder of the Highland Capital Management. He started the company in 1993 and has continuously led the company. Jim started out as a Certified Financial Analyst before starting the company. He majored in Accounts and Finance in the University of Virginia and graduated with the highest honors. Initially, he worked for American Express as a Portfolio Manager. Moreover, he worked on GIC subsidiary as a CFA analyst. With the experience, Jim Dondero is a designated user of the CFA title.
Octafinance,. “HIGHLAND CAPITAL MANAGEMENT Top 10 Holdings In Q3 2015 – Octafinance”. N.p., 2016. Web. 16 Feb. 2016. via http://www.octafinance.com/highland-capital-management-top-10-holdings-in-q3-2015/352793/